ERILF yields 20000.00% · JNJ yields 2.14%● Live data
📍 ERILF pulled ahead of the other in Year 1
Combined, ERILF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of ERILF + JNJ for your $10,000?
Dynamic Technologies Group Inc. designs, builds, and installs entertainment attractions and ride systems for the entertainment industry. The company operates through Ride Systems Manufacturing, and Parts and Service segments. It also applies turn-key integration services for special projects, such as alternative energy, large optical telescopes, and enclosures, as well as custom steel fabrication services. In addition, the company provides custom design-build-commission services for custom ride systems and attractions, as well as parts and services to park operators for its own ride systems and those ride systems supplied by others. Further, it owns and operates the SkyFlyTM Soar America flying theater attraction at the Island in Pigeon Forge theme park in Tennessee; provides design engineering and product research and development services for complex ride systems; and designs integrated structures, such as astronomical telescope enclosures for third party customers. The company serves theme parks, stand-alone tourist venues, and the government sector in Canada, the United States, Asia, the Middle East, and Europe. The company was formerly known as Empire Industries Ltd. and changed its name to Dynamic Technologies Group Inc. in March 2021. Dynamic Technologies Group Inc. was founded in 1926 and is headquartered in Toronto, Canada.
Full ERILF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.